Ozempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5 - eviltoast
  • frazw@lemmy.world
    link
    fedilink
    English
    arrow-up
    14
    arrow-down
    16
    ·
    8 months ago

    This will be unpopular, but a new drug costs a fuck-ton of money to bring to market. It might only cost a few dollars to produce but it certainly didn’t cost that to develop. Yeah, the price is excessive but it certainly couldn’t sell for $1 right now.

    It’s really easy to ignore that and think only about the material cost of production. They also presumably want to see some profit to fuel future R&D.

    For insulin, there is no excuse. Its development is long since paid for. A moderate mark up is acceptable to incentive the companies to produce it and maybe pay for R&D of some other drug but beyond that it is just greed.

    The companies have a moral responsibility to make life saving drugs affordable, but they also need a revenue stream to develop them in the first place.

    I know someone will take exception and talk about ceo bonuses etc. Let me get in first and say I agree. They shouldn’t get millions in bonuses at the expense of people forced to pay exorbitant costs to them just to keep on living.

    • KevonLooney@lemm.ee
      link
      fedilink
      English
      arrow-up
      22
      ·
      8 months ago

      They also presumably want to see some profit to fuel future R&D.

      A lot of these companies spend more on marketing than R&D. If they want help lowering their costs, we can ban pharmaceutical advertisements like the rest of the world does.

      Testing costs prevent drugs that will save a few lives from being tested. Instead, hair growth, penis pills, and now weight loss drugs are being developed. A million people with smaller issues are more profitable than one person with a severe issue.

      Drugs should be developed and tested through public private partnerships with universities. That could be paired with limitations on drug prices. We shouldn’t even trust drug companies to do the testing. That would take a long way a lot of their costs. I doubt they’d like it though.

      • frazw@lemmy.world
        link
        fedilink
        English
        arrow-up
        5
        ·
        8 months ago

        I forget about the marketing part because here, there isn’t any direct marketing to the public. I always thought it was odd on US TV, “tell you doctor to prescribe…” No. The trained professional should be deciding which drug to prescribe.

        Marketing to doctors also is a thing I guess, but there is some insulation from that in a nationalised health care system.

        • vrek@programming.dev
          link
          fedilink
          English
          arrow-up
          3
          ·
          8 months ago

          I often read arstechnica.com and one thing that annoys me is I often see prescription ads on their site. Most of the time I don’t even know the illness they are trying to cure. Honestly I wonder how effective those ads are. Like who goes to a doctor like “I saw this ad for miracle pill and people at the end were happy. Give me that pill” and the doctor doesn’t go “that’s for an enlarged liver which you don’t have… Why do you want that pill?”

          • ____@infosec.pub
            link
            fedilink
            English
            arrow-up
            2
            ·
            8 months ago

            The handful of meds I’ve asked for after having seen any advertising at all, the advertising was incidental. I followed Sunosi for a decade before it was approved and I asked for it. The ads weren’t a part of it.

            I followed the eight hour version of sodium oxybate for about the same amount of time, and ended up disillusioned with it because of the risk of getting no fucking sleep at all if the first dose failed.

            Patients who are able absolutely should follow the promising compounds under development. I had a similar experience with provigil, waaaay back when there was nothing else except methylphenidate.

            DTC advertising needs to go away.

            Patients need to be more informed about the pipeline and current studies.

            Both can be true.

    • Lmaydev@programming.dev
      link
      fedilink
      English
      arrow-up
      10
      arrow-down
      1
      ·
      edit-2
      8 months ago

      Indeed, but they could stick a couple 100 percent markup on it and make their money back.

      20000% is obscene.

      They also often get a lot of public funding.

      • frazw@lemmy.world
        link
        fedilink
        English
        arrow-up
        3
        ·
        8 months ago

        Absolutely. It is obscene and I’m not trying to defend that My point was just that saying I could make it for this amount means nothing if I didn’t have to pay to develop it as well.